levobupivacaine + morphine

Levobupivacaine + morphine is a combination of two pharmaceutical agents used primarily for pain management, especially in the context of postoperative and cancer-related pain. Levobupivacaine is a long-acting amide-type local anesthetic that blocks voltage-gated sodium channels, inhibiting nerve impulse transmission and providing regional anesthesia. Morphine is an opioid analgesic that acts as an agonist at mu-opioid receptors in the central nervous system, altering the perception and response to pain. When administered together—commonly via epidural or intrathecal routes—the combination provides superior analgesia compared to either agent alone by leveraging both peripheral (local anesthetic) and central (opioid) mechanisms of action. This synergy allows for improved pain control with potentially lower doses of each drug, reducing some side effects associated with higher single-agent dosing[1][6]. The combination has been studied in various surgical settings (e.g., abdominal surgery, orthopedic procedures) and for chronic malignant pain.

Other names

morphine and levobupivacainelevobupivacaine and morphine